Insulet Corporation (GOV F) stock market data APIs
€224.0922
-4.42(-1.9%)
as of March 12, 2025
Insulet Corporation Financial Data Overview
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Prev. Close
228.5095
Open
224.0922
High
228.318
Low
224.0922
52 wk Range
147.2-277.3
Market Cap
16 184 M
P/E Ratio
42.397
Shares Outstanding
70 226 K
Revenue
2 072 M
Beta
1.287
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Insulet Corporation data using free add-ons & libraries
Get Insulet Corporation Fundamental Data
Insulet Corporation Fundamental data includes:
- Net Revenue: 2 072 M
- EBITDA: 390 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-20
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Insulet Corporation News
New
Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease
Insulet experienced a 12% decline in its stock price over the past week following its earnings announcement and corporate guidance. The company reported strong year-over-year sales growth, however, ne...
Insulet to Host Investor Day on June 5, 2025
ACTON, Mass., March 11, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, ...
Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth
It might be of some concern to shareholders to see the Insulet Corporation (NASDAQ:PODD) share price down 11% in the last month. But the silver lining is the stock is up over five years. However we ar...
Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls
https://www.tipranks.com/news/the-fly/robinhood-initiated-mongodb-downgraded-wall-streets-top-analyst-calls The most talked about and market moving research calls around Wall Street are now in one pl...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
